Buscar
Vaxcyte Inc
PCVXAñadir a la lista de seguimiento
54.080USD
-1.880-3.36%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
7.81BCap. mercado
PérdidaP/E TTM
Más Datos de Vaxcyte Inc Compañía
Vaxcyte Inc. is a clinical-stage vaccine innovation company. The Company is engaged in developing spectrum conjugate and protein vaccines to prevent or treat bacterial infectious diseases. Its pipeline includes VAX-31, a 31-valent PCV candidate advancing to a Phase III adult clinical program and being evaluated in a Phase II infant clinical program, which is being developed for the prevention of invasive pneumococcal disease (IPD) in adults and infants and is the broadest-spectrum pneumococcal conjugate vaccine (PCV) candidate in the clinic. VAX-24, the Company’s 24-valent PCV candidate, is designed to cover more serotypes than any infant PCV on-market and is being evaluated in a Phase II infant study. Its pipeline also includes VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease; and VAX-GI, a vaccine candidate designed to prevent Shigella.
Información de Vaxcyte Inc
Símbolo de cotizaciónPCVX
Nombre de la empresaVaxcyte Inc
Fecha de salida a bolsaJun 12, 2020
Director ejecutivoPickering (Grant E)
Número de empleados414
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 12
Dirección825 Industrial Road, Ste. 300
CiudadSAN CARLOS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94070
Teléfono16508370111
Sitio Webhttps://vaxcyte.com/
Símbolo de cotizaciónPCVX
Fecha de salida a bolsaJun 12, 2020
Director ejecutivoPickering (Grant E)
Ejecutivos de Vaxcyte Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Grant E. Pickering
Mr. Grant E. Pickering
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
560.66K
-7.93%
Mr. Andrew L. Guggenhime
Mr. Andrew L. Guggenhime
President, Chief Financial Officer
President, Chief Financial Officer
96.84K
--
Ms. Teri Loxam
Ms. Teri Loxam
Independent Director
Independent Director
9.44K
+23.99%
Dr. Carlos V. Paya, M.D., Ph.D.
Dr. Carlos V. Paya, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
9.44K
+23.99%
Mr. Jacks Lee
Mr. Jacks Lee
Independent Director
Independent Director
3.81K
+59.37%
Mr. Mikhail Eydelman, J.D.
Mr. Mikhail Eydelman, J.D.
Senior Vice President, General Counsel, Chief Compliance Officer, Corporate Secretary
Senior Vice President, General Counsel, Chief Compliance Officer, Corporate Secretary
2.56K
-392.15%
Mr. John P. Furey
Mr. John P. Furey
Independent Director
Independent Director
2.27K
--
Dr. Olivier Brandicourt
Dr. Olivier Brandicourt
Independent Director
Independent Director
2.19K
--
Mr. James (Jim) Wassil
Mr. James (Jim) Wassil
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
1.63K
-106.51%
Ms. Halley E. Gilbert, J.D.
Ms. Halley E. Gilbert, J.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Grant E. Pickering
Mr. Grant E. Pickering
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
560.66K
-7.93%
Mr. Andrew L. Guggenhime
Mr. Andrew L. Guggenhime
President, Chief Financial Officer
President, Chief Financial Officer
96.84K
--
Ms. Teri Loxam
Ms. Teri Loxam
Independent Director
Independent Director
9.44K
+23.99%
Dr. Carlos V. Paya, M.D., Ph.D.
Dr. Carlos V. Paya, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
9.44K
+23.99%
Mr. Jacks Lee
Mr. Jacks Lee
Independent Director
Independent Director
3.81K
+59.37%
Mr. Mikhail Eydelman, J.D.
Mr. Mikhail Eydelman, J.D.
Senior Vice President, General Counsel, Chief Compliance Officer, Corporate Secretary
Senior Vice President, General Counsel, Chief Compliance Officer, Corporate Secretary
2.56K
-392.15%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Vaxcyte Inc?
Los cinco principales accionistas de Vaxcyte Inc son: Mr. Grant E. Pickering
¿Cuántas instituciones poseen acciones de Vaxcyte Inc (PCVX)?
A fecha de 2026Q1, 718 instituciones poseen acciones de Vaxcyte Inc, con un valor de mercado combinado de aproximadamente 151.93M, lo que representa el 105.22% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -5247062.00.